Suppr超能文献

对世界卫生组织-联合国环境规划署《内分泌干扰化学物质科学现状(2012年)》的批判性评论

Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012.

作者信息

Lamb James C, Boffetta Paolo, Foster Warren G, Goodman Julie E, Hentz Karyn L, Rhomberg Lorenz R, Staveley Jane, Swaen Gerard, Van Der Kraak Glen, Williams Amy L

机构信息

Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA.

The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, 17 East 102 Street Floor West Tower, 5th Floor Room 5-142, New York, NY 10029, USA.

出版信息

Regul Toxicol Pharmacol. 2014 Jun;69(1):22-40. doi: 10.1016/j.yrtph.2014.02.002. Epub 2014 Feb 13.

Abstract

Early in 2013, the World Health Organization (WHO) released a 2012 update to the 2002 State of the Science of Endocrine Disrupting Chemicals. Several significant concerns have been identified that raise questions about conclusions reached in this report regarding endocrine disruption. First, the report is not a state-of-the-science review and does not follow the 2002 WHO recommended weight-of-evidence approach. Second, endocrine disruption is often presumed to occur based on exposure or a potential mechanism despite a lack of evidence to show that chemicals are causally established as endocrine disruptors. Additionally, causation is often inferred by the presentation of a series of unrelated facts, which collectively do not demonstrate causation. Third, trends in disease incidence or prevalence are discussed without regard to known causes or risk factors; endocrine disruption is implicated as the reason for such trends in the absence of evidence. Fourth, dose and potency are ignored for most chemicals discussed. Finally, controversial topics (i.e., low dose effects, non-monotonic dose response) are presented in a one-sided manner and these topics are important to understanding endocrine disruption. Overall, the 2012 report does not provide a balanced perspective, nor does it accurately reflect the state of the science on endocrine disruption.

摘要

2013年初,世界卫生组织(WHO)发布了《2002年内分泌干扰化学物科学现状》的2012年更新版。已发现了几个重大问题,这些问题对该报告中有关内分泌干扰的结论提出了质疑。首先,该报告并非科学现状综述,也未遵循2002年WHO推荐的证据权重方法。其次,尽管缺乏证据表明化学物被因果性地确定为内分泌干扰物,但往往基于暴露或潜在机制就假定发生了内分泌干扰。此外,因果关系常常是通过呈现一系列不相关的事实来推断的,而这些事实总体上并未证明因果关系。第三,在讨论疾病发病率或患病率趋势时,未考虑已知病因或风险因素;在没有证据的情况下,将内分泌干扰归咎于此类趋势的原因。第四,对于所讨论的大多数化学物,剂量和效力都被忽略了。最后,有争议的话题(即低剂量效应、非单调剂量反应)以片面的方式呈现,而这些话题对于理解内分泌干扰很重要。总体而言,2012年报告没有提供一个平衡的观点,也没有准确反映内分泌干扰的科学现状。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验